Organization: Health Canada
Year: 2024
Month: March
Request Number: A-2023-000584
Request Summary: With respect to generic drug i Health Canada's list of "Generic Drug Submissions Under Review" dated 2022-01-19 for the medicinal ingredient liraglutide, any document that would indicate the current status of the submission, such as but not limited to, an Acknowledgment Letter, Notice of Defiency (NOD), Notice of Non-Compliance (NON), NOD-Withdrawal (NOD-W), NOD-Withdrawal (NOD-W), or sponsor's letter requesting cancellation of their submission.
Disposition: Disclosed in part
Number of pages: 1